Teva Pharmaceutical Industries Ltd (ADR) (NASDAQ:TEVA)
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
2KHERBS
(< 20)
Submitted: 9/19/2009 7:30:04 PM :
Start Price:
$49.63
TEVA Score:
-46.96
Drugs coming off patent will make TEVA profitable. Their lean business model and cash flow is a plus.
Recs
dhd1491
(95.04)
Submitted: 9/16/2009 3:42:37 PM :
Start Price:
$49.39
TEVA Score:
-48.48
Teva will be a dividend monster of the future. Teva has increased its dividend each year by 34% average over the last ten years. Aging of developed nations' population will drive demand for pharmaceuticals in general for the remainder of our lives (anyone reading this). Generics, in particular, will benefit from the current effort to rein in escalating health costs. Teva, the largest generic-maker in the world, is right in the sweet spot for top line growth. At a forward PE of less than 12, Teva is an incredible bargain for a company that should double sales every 4-5 years. Current market angst over loss of Copaxone patent and worry about indigestion from Barr acquisition are holding the lid on this stock; short-term static, in my opinion. Buy this stock now and hold forever.
Recs
michaeltbryant
(< 20)
Submitted: 9/13/2009 11:46:13 PM :
Start Price:
$49.35
TEVA Score:
-49.54
Generics is the future.
Recs
PL1000
(95.42)
Submitted: 8/25/2009 7:36:27 PM :
Start Price:
$50.28
TEVA Score:
-52.25
genaric will win out and this is a strong contender.i like it enought to buy it ,even though i feel a financial set back is ready this friday 8/26/2009 or next week.
Recs
cashandgrab
(< 20)
Submitted: 8/20/2009 4:55:35 PM :
Start Price:
$50.17
TEVA Score:
-53.42
More people getting older-faster, more drugs = more money
Recs
shreebs
(< 20)
Submitted: 8/17/2009 4:40:10 AM :
Start Price:
$48.73
TEVA Score:
-54.96
Extremely defensive and while the bad news on Barr will hurt the mkt will overeact and then come running back to Teva to find a place to hide from the coming correction.
Recs
MeridianGuy
(< 20)
Submitted: 8/11/2009 11:16:29 PM :
Start Price:
$49.59
TEVA Score:
-55.46
Generics, Generics, Generics.
Recs
angel696i
(< 20)
Submitted: 7/21/2009 6:04:15 AM :
Start Price:
$47.81
TEVA Score:
+57.69
TEVA is a "defensive" stock. not something that will boost your portfolio when the market goes bull.
people think its Generics, but 30% from TEVA's income is from ethics products - copaxone (for MS) and expose to generics competition. no biogenerics (FOB) in USA means no way to grow in the next 5 years after copaxone loses its patent.
Recs
crash4556
(< 20)
Submitted: 7/7/2009 9:34:33 AM :
Start Price:
$47.52
TEVA Score:
-67.70
positive earnings
Recs
Ronz8In
(< 20)
Submitted: 6/15/2009 11:28:42 PM :
Start Price:
$46.05
TEVA Score:
-59.34
Generics are the future of healthcare with national health insurance.
Recs
jackysam
(< 20)
Submitted: 5/5/2009 11:25:53 AM :
Start Price:
$41.71
TEVA Score:
-55.36
this co. appears to be recession proof
Recs
VoodooEconomist
(36.53)
Submitted: 5/4/2009 1:04:47 PM :
Start Price:
$42.28
TEVA Score:
-57.36
Best in the generic drug field. Generic drugs aren't high margin, so high volume gives the competitive advantange.
Recs
Lindford1234
(< 20)
Submitted: 3/31/2009 6:55:09 AM :
Start Price:
$42.84
TEVA Score:
-77.64
This is a winner. Great company all around! Go with it.
Recs
Recs
worship1god
(61.73)
Submitted: 3/13/2009 11:33:30 AM :
Start Price:
$42.90
TEVA Score:
-88.82
Generics are the future
Recs
Recs
TomFoolNC
(95.66)
Submitted: 3/2/2009 1:45:32 PM :
Start Price:
$41.51
TEVA Score:
-96.01
generic drugs under new admin
Recs
rmercer21
(< 20)
Submitted: 2/27/2009 6:27:10 PM :
Start Price:
$41.84
TEVA Score:
-93.12
Increased government spending on medical care will force more attention on generics, plus their drug copaxone still has not seen successful competition as yet. Until that happens they will be very profitable. It is a very well managed company.
Recs
theuscsuperfan
(84.23)
Submitted: 2/27/2009 3:45:59 PM :
Start Price:
$42.72
TEVA Score:
-89.75
This is a hedge against my current holdings in AMGN. The future of generic drugs seems bright, whether it be from the U.S. allowing the importing of foreign drugs or allowing patents o expire without extensions. The population is getting older, they want more affordable drugs, and the government panders to the elderly because they vote.
Recs
fladoy
(97.36)
Submitted: 2/20/2009 11:14:26 AM :
Start Price:
$44.26
TEVA Score:
-87.93
Teva Pharmaceutical Industries develops and markets generic pharmaceuticals. The stock broke past a tight $41.50 to $43.25 trading range after the company reported 2008 results. Highlights from the announcement include: 2009 guidance of $3.20 to $3.40 earnings per share, fourth quarter earnings of $0.76 beat analyst estimates by $0.03, and the dividend is increasing. The stock currently trades at 15 times current EPS and a miniscule 11 times forward EPS.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 181 - 200 of 411 : « Previous 5 6 7 8 9 10 11 12 13 14 Next »